問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2025-10-18

魏鈺儒
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

9Cases

2025-12-01 - 2032-08-02

Others

Active
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
  • Condition/Disease

    Primary Biliary Cholangitis

  • Test Drug

    膠囊劑

Participate Sites
7Sites

Not yet recruiting7Sites

2026-10-01 - 2030-04-08

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Not yet recruiting4Sites

2026-01-01 - 2029-08-31

Phase I/II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Not yet recruiting4Sites

2026-08-05 - 2030-03-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Not yet recruiting1Sites

2026-03-08 - 2027-06-15

Phase I

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Not yet recruiting2Sites

Recruiting3Sites

2025-01-01 - 2032-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
12Sites

Recruiting12Sites

2025-01-01 - 2030-01-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Recruiting11Sites

2026-01-01 - 2032-03-10

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
15Sites

Not yet recruiting8Sites

Recruiting7Sites

2026-01-13 - 2028-07-24

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Not yet recruiting1Sites

Recruiting2Sites